ATS (ATS) Stock

ATS, AZUL and BBC have been added to the Zacks Rank #5 (Strong Sell) List on October 4, 2024.

ATS provides vertically integrated automation solutions, focusing on Life Sciences and F&B sectors, with a robust backlog and strategic acquisitions enhancing growth potential. The macroeconomic environment, including lower interest rates and demographic changes, supports ATS's growth, especially in reshoring economies and increasing efficiency demands. Despite a healthy balance sheet, ATS faces risks from supply chain issues and cyclical industry exposure, with upcoming restructuring costs impacting short-term performance.

ATS, BMTX and B have been added to the Zacks Rank #5 (Strong Sell) List on September 13, 2024.

CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) today announced that Andrew Hider, Chief Executive Officer and Ryan McLeod, Chief Financial Officer will participate in the Jefferies Industrials Conference in New York City, NY on September 5, 2024. ATS is scheduled to host a fireside chat at the event at 2:30 p.m. (ET). A webcast link of the live event will be available on the Investor Relations site at https://investors.atsautomation.com/ in.

ATS Corporation (NYSE:ATS ) Q1 2025 Results Conference Call August 8, 2024 8:30 AM ET Company Participants David Galison - Head of Investor Relations Andrew Hider - Chief Executive Officer Ryan McLeod - Chief Financial Officer Conference Call Participants Michael Glen - Raymond James Patrick Sullivan - TD Cowen Joe Ritchie - Goldman Sachs Justin Keywood - Stifel Maxim Sytchev - National Bank Financial David Ocampo - Cormark Securities Patrick Baumann - JPMorgan Operator Hello, everyone, and welcome to the ATS Corporation First Quarter Conference Call and Webcast. This call is being recorded on August 8, 2024 at 8:30 a.m.

ATS (ATS) came out with quarterly earnings of $0.37 per share, missing the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.51 per share a year ago.

ATS (ATS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) will report its financial results for the first quarter ended June 30, 2024, before markets open on Thursday August 8, 2024. At 8:30 a.m. eastern August 8, 2024, the Company will host a conference call and webcast of management's quarterly remarks and follow up question and answer period with analysts. The listen-only webcast can be accessed at https://events.q4inc.com/attendee/283321487, and th.

KT-621, a potent, selective, oral STAT6 degrader, demonstrated comparable or superior activity to dupilumab in preclinical studies including an asthma model shared at the ATS Annual Meeting